Inhibition of viral RNA-dependent RNA polymerases with clinically relevant nucleotide analogs

Abstract

The treatment of viral infections remains challenging, in particular in the face of emerging pathogens. Broad-spectrum antiviral drugs could potentially be used as a first line of defense. The RNA-dependent RNA polymerase (RdRp) of RNA viruses serves as a logical target for drug discovery and development efforts. Herein we discuss compounds that target RdRp of poliovirus, hepatitis C virus, influenza viruses, respiratory syncytial virus, and the growing data on coronaviruses. We focus on nucleotide analogs and mechanisms of action and resistance.

Keywords: Antivirals; Coronavirus; Hepatitis C virus; Influenza virus; Nucleotide analogs; Poliovirus; RNA virus; Respiratory syncytial virus; Viral polymerase inhibitor.